Although it is clear that methylation of the RUNX3 promoter region is one of the ways in which this gene can be inactivated in CRC, other mechanisms including mislocalisation of RUNX3 protein could also be occurring. The gene discussed is RUNX3; the disease is colorectal carcinoma.